Related Experiment Video
Updated: Jun 24, 2026
09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Benign lesions accompanied by intractable epilepsy in children
George A Alexiou1, Maria Varela, George Sfakianos
1Department of Neurosurgery, Children's Hospital Agia Sofia, Athens, Greece. alexiougrg@yahoo.gr
Journal of Child Neurology
|March 18, 2009
Summary
Pediatric epilepsy surgery offers a safe and effective treatment for children with intractable epilepsy, particularly those with brain abnormalities. This study found that 79% of young patients became seizure-free after surgery, with no lasting complications.
Area of Science:
- Pediatric Neurosurgery
- Epileptology
- Neuropathology
Background:
- Intractable epilepsy in children often necessitates surgical intervention, especially when structural brain abnormalities are present.
- Epilepsy surgery is considered a viable treatment option for pediatric patients with drug-resistant seizures.
Purpose of the Study:
- To evaluate the safety and efficacy of epilepsy surgery in children with intractable epilepsy.
- To analyze the types of brain lesions and their locations in pediatric epilepsy surgery cases.
- To determine seizure outcomes and complication rates following surgical treatment.
Main Methods:
- A cohort of 24 children with intractable epilepsy underwent surgical resection of brain lesions.
- Histopathological examination identified various lesions including ganglioglioma, dysembryoplastic neuroepithelial tumors, glioma, cortical dysplasia, and cavernous malformations.
- Patients were followed up for a mean of 4.4 years to assess seizure status and neurological outcomes.
Main Results:
- The majority of lesions (18/24) were located in the temporal lobe.
- Seventy-nine percent (19/24) of the pediatric patients achieved seizure freedom post-surgery.
- No permanent neurological deficits or deaths were reported, indicating a safe surgical profile.
Conclusions:
- Epilepsy surgery is a safe and effective procedure for treating intractable focal epilepsy in children.
- Surgical intervention can lead to significant seizure reduction and improved quality of life in pediatric patients.
- Early surgical consideration for children with specific brain abnormalities and intractable epilepsy is warranted.
Related Concept Videos
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...